Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID

Area of Science:

• Gastroenterology
• Bariatric Surgery
• Inflammatory Bowel Disease

Background:

• Rising rates of obesity and bariatric surgery (BS) in general and inflammatory bowel disease (IBD) populations.
• Limited data on BS safety and efficacy in IBD patients due to small sample sizes and lack of controls.

Purpose of the Study:

• To evaluate the safety, weight loss, and nutritional deficiencies in obese IBD patients after BS.
• To compare outcomes of BS in IBD patients versus a matched control group without IBD.

Main Methods:

• Retrospective study of 85 IBD patients (64 Crohn's disease, 20 ulcerative colitis) who underwent BS.
• Matched 1:2 with non-IBD patients for age, sex, BMI, hospital, and BS type.
• Collected data on complications, rehospitalizations, weight, and deficiencies.

Main Results:

• 88 procedures performed; mean BMI 41.6 kg/m2. Sleeve gastrectomy was most common (n=73).
• 9% complications reported (4% surgical). Mean follow-up: 34 months.
• No significant differences between IBD and control groups in postoperative complications, weight loss, or deficiencies.

Conclusions:

• Bariatric surgery is a safe and effective option for managing obesity in patients with IBD.
• Outcomes for IBD patients undergoing BS are comparable to those in the general population.